The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals
Open accessAbstract
Objectives: Amyloid‐beta (Aβ) and tau pathologies are commonly observed among clinically normal older individuals at postmortem and can now be detected with in vivo neuroimaging. The association and interaction of these proteinopathies with prospective cognitive decline in normal aging and preclinical Alzheimer's disease (AD) remains to be fully elucidated. Methods: One hundred thirty‐seven older individuals (age = 76.3 ± 6.22 years) participating in the Harvard Aging Brain Study underwent Aβ ( 11 C‐Pittsburgh compound B) and tau ( 18 F‐flortaucipir) positron emission tomography (PET) with prospective neuropsychological assessments following PET imaging (mean number of cognitive visits = 2.8 ± 1.1). Tau and Aβ PET measures were assessed in regions of interest (ROIs) as well as vertex‐wise map analyses. Cognitive change was evaluated with Memory and Executive Function composites. Results: Higher levels of Aβ and tau were both associated with greater memory decline, but not with change in executive function. Higher cortical Aβ was associated with higher tau levels in all ROIs, independent of age, and very elevated levels of tau were observed primarily in clinically normal with elevated Aβ. A significant interaction between tau and Aβ was observed in both ROI and map‐level analyses, such that rapid prospective memory decline was observed in participants who had high levels of both pathologies. Interpretation: Our results are consistent with the supposition that both Aβ and tau are necessary for memory decline in the preclinical stages of AD. These findings may be relevant for disambiguating aging and early cognitive manifestations of AD, and to inform secondary prevention trials in preclinical AD. Ann Neurol 2019;00:1–3 ANN NEUROL 2019;85:181–193.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regional specificity of these findings aligns with evidence that entorhinal cortex is a site of preclinical neuropathological tau deposition that is elevated for APOE4 carriers [37] and predicts cognitive decline [38], and which undergoes accelerated atrophy in preclinical AD [39].”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“Autopsy reports suggest that tau deposition in the entorhinal cortex (EC) is nearly ubiquitous in advanced aging, whereas spread into the surrounding temporal neocortex is less commonly observed among CN older individuals, particularly in the absence of substantial Aβ pathology.(18) It remains unclear whether EC tau a…”
BackgroundPreclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citationFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Tau positron emission tomographic imaging in aging and early Alzheimer disease
Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., Mormino, E., Chhatwal, J., Amariglio, R., Papp, K., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24546 · Cited by 986
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–287 of 287
Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series.
James, O. G., Linares, A. R., Hellegers, C., Doraiswamy, P., & Wong, T. (2021) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003493 · Cited by 4
Simon, S. S., Varangis, E. M. L., Lee, S., Gu, Y., Gazes, Y., Razlighi, Q. R., Habeck, C. G., & Stern, Y. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.10.001 · Cited by 5
Lack of occlusal support did not impact amyloid β deposition in APP knock-in mice
Murakami, A., Hara, T., Yamada-Kubota, C., Kuwahara, M., Ichikawa, T., & Minagi, S. (2021) · Journal of Prosthodontic Research · doi:10.2186/jpr.jpr_d_20_00205 · Cited by 5
Neuroimaging and clinical characteristics of cognitive migration in community-dwelling older adults
Duran, T., Bateman, J. R., Williams, B. J., Espeland, M. A., Hughes, T. M., Okonmah‐Obazee, S. E., Rundle, M. M., Craft, S., & Lockhart, S. N. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103232 · Cited by 6
Zhou, J., Sun, X., Wang, K., Shen, M., Yu, J., Yao, Q., Hong, H. S., Tang, C., & Wang, Q. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01399-z · Cited by 4
Role of Monoclonal Antibodies in Alzheimer’s Disease: Successes, Failures, and Future Directions
Gupta, A., Pahal, S., Kumar, V., & Chaudhary, A. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08456-5 · Cited by 5
Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths
Maboudian, S. A., Fonseca, C. S., Martersteck, A., Chao, Y., Chen, Y., Ushizima, D. M., Tosun, D., Grinberg, L. T., Weiner, K. S., Jagust, W. J., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78166 · Cited by 4
Fu, J. F., Garimella, A. H., Lapointe, A., Aye, W. W. T., Chen, C. D., Lee, J. H., Krinsky‐McHale, S. J., Zaman, S. H., Lott, I. T., Hom, C. L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70424 · Cited by 3
Self-citationWeinstein, A. M., Fang, F., Chang, C. H., Cohen, A. D., Lopresti, B. J., Laymon, C. M., Nadkarni, N. K., Aizenstein, H. J., Villemagne, V. L., Kamboh, M. I., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241303926 · Cited by 4
Zhang, R., Initiative, A. D. N., Chen, S.-D., Shen, X., Yang, Y., Lu, J., Cui, M., Zuo, C., Dong, Q., Tan, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200526 · Cited by 4
Deng, S., Tan, S., Song, X., Lin, X., Yang, K., Li, X., & Initiative, A. D. N. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14859 · Cited by 3
Yeung, L., Hale, C., Last, B. S., Andrews, H., Sloan, R. P., Honig, L. S., Small, S. A., & Brickman, A. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.010 · Cited by 4
Predicting Risk for Dementia: Is It Ready for the Clinic?
Johnson, S. C., & Asthana, S. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19050520 · Cited by 4
Cushing, S. D., Moseley, S. C., Stimmell, A. C., Schatschneider, C. W., & Wilber, A. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599921 · Cited by 3
Bayıl, S., Tozlu, Ö. Ö., & Karagul, B. (2025) · Science in progress · doi:10.1177/00368504251384830 · Cited by 3
Bachmann, D., Wybitul, M., Buchmann, A., Gericke, C., Saake, A., Studer, S. T., Rauen, K., Gruber, E., Blennow, K., Zetterberg, H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70802 · Cited by 5
He, H., Razlighi, Q. R., Gazes, Y., Habeck, C. G., Stern, Y., Initiative, A. D. N., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., Jack, C. R., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01170-5 · Cited by 5
Cody, K. A., Sokolowski, A., Johns, E., Guerra, L. M., Winer, J. R., Young, C. B., Younes, K., Dumitrescu, L. C., Archer, D. B., Durant, A., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71017 · Cited by 3
Self-citationManagement of Alzheimer’s Disease with nutraceuticals
Yadav, J. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00028-8 · Cited by 3
Ronat, L. A., Hanganu, A., Chylinski, D., Egroo, M. V., Narbutas, J., Besson, G., Muto, V., Schmidt, C., Bahri, M. A., Phillips, C. L. M., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12131-0 · Cited by 3
Dubbelman, M. A., Diez, I. P., Gonzalez, C., Amariglio, R. E., Becker, J. A., Chhatwal, J. P., Gatchel, J. R., Johnson, K. A., Locascio, J. J., Udeogu, O. J., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1420290 · Cited by 3
Self-citationArmstrong, C., Luo, D., Gretzinger, A., Pandey, D., Lipchik, A. M., Todi, S. V., & Dutta, A. K. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00220 · Cited by 3
Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer’s disease
Phang, S. K. A., Tan, C. H., & Initiative, A. D. N. (2025) · GeroScience · doi:10.1007/s11357-025-01541-9 · Cited by 6
Stojanovic, M., Millar, P. R., McKay, N. S., Aschenbrenner, A. J., Balota, D. A., Hassenstab, J. J., Benzinger, T. L. S., Morris, J. C., & Ances, B. M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251316801 · Cited by 3
Rosenich, E., & Lim, Y. Y. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01776-w · Cited by 3
Behaviorally meaningful functional networks mediate the effect of Alzheimer’s pathology on cognition
Ziontz, J., Harrison, T. M., Chen, X., Giorgio, J., Adams, J. N., Wang, Z., Jagust, W. J., & Initiative, A. D. N. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae134 · Cited by 3
Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
Terao, C. M., Alexander, M. W., Chalmers, R. P., Boshmaf, S. Z., Paterson, J., Black, S. E., Papp, K. V., Sperling, R. A., & Rabin, J. S. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70052 · Cited by 3
Self-citationWhite matter hyperintensities may be an early marker for age-related cognitive declinePreprint
Morrison, C., Dadar, M., Villeneuve, S., Collins, D. L., & Initiative, A. D. N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.23.461560 · Cited by 3
Amyloid-β-regulated gene circuits for programmable Alzheimer’s disease therapyPreprint
Spetz, M. R., Kim, H., Ligocki, A. P., Shekharan, S. R., Brien, H. J., Chavarría, D., Conger, D. J., Shattuck-Brandt, R. L., Shostak, A., Embalabala, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.12.642808 · Cited by 3
Paulsen, A. J., Driscoll, I. F., Breidenbach, B. M., Glittenberg, M., Lose, S. R., Ma, Y., Sager, M. A., Carlsson, C. M., Gallagher, C. L., Hermann, B. P., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70122 · Cited by 2
Jutten, R. J., Burling, J. E., Slade, E., Thompson, J. C., Fu, J. F., Birkenbihl, C., Properzi, M. J., Marshall, G. A., Amariglio, R. E., Papp, K. V., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70160 · Cited by 2
Self-citationComparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease
Wisch, J. K., McKay, N. S., Zammit, M. D., Christian, B. T., Schultz, S. A., Millar, P. R., Ryan, N. S., Cash, D. M., Belder, C. R. S., Chrem, P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70812 · Cited by 2
He, H., Zhang, C., Yu, D., Gao, X., Wei, C., & Ding, W. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.121108 · Cited by 3
Higher Amyloid and Tau Burden Is Associated With Faster Decline on a Digital Cognitive Test
Fu, J. F., Robinson, T. L., Alonso, M. R., Francis-Malavé, A. M., Jutten, R. J., Properzi, M. J., Healy, B. C., Thompson, J. C., Montenegro, G. D. C., Thibault, E. G., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70233 · Cited by 2
Self-citationDeclaration of Competing Interest
Cui, W., & Xiang, L. (2024) · Wiley eBooks · doi:10.1002/9783527845583.oth1 · Cited by 3
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Aβ remotely and locally facilitates Alzheimer’s disease tau spreading
Nabizadeh, F., Initiative, A. D. N., & Nabizadeh, F. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae386 · Cited by 1
Shafigh, E., Sadeghi, G., Jamaat, N. A., Hassanpour, F., Solhirad, M., & Karimi‐Zandi, L. (2025) · Current Alzheimer Research · doi:10.2174/0115672050386593250521064527 · Cited by 1
A Pilot Study on Blood Concentration of β-Amyloid (40 and 42) and Phospho-Tau 181 in Horses
Gazzano, V., Curadi, M. C., Capsoni, S., Baragli, P., Kędzierski, W., Cecchi, F., & Gazzano, A. (2025) · Veterinary Sciences · doi:10.3390/vetsci12070610 · Cited by 1
Zhong, P., Shaker, T., Li, P., & Yan, Z. (2026) · The Journal of Physiology · doi:10.1113/jp289018 · Cited by 1
Amyloid-beta relates to default and attention network connectivity during working memory retrieval
He, H., Habeck, C. G., & Stern, Y. (2026) · Brain Communications · doi:10.1093/braincomms/fcag278 · Cited by 1
Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease
Vanderlip, C. R., & Stark, C. E. L. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71834 · Cited by 1
Cognitive Aging and the Transition to Early Alzheimer’s Disease
Mormino, E. C., & Jagust, W. J. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190917982.013.59 · Cited by 1
Self-citationAlzheimer’s Disease, the Parietal Lobes, and the Evolution of the Human Genus
Bruner, E., & Jacobs, H. I. L. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197676592.003.0009 · Cited by 1
Self-citationWagemann, O., Brendel, M., Franzmeier, N., Nübling, G., Gnörich, J. S., Zaganjori, M., Prix, C., Stockbauer, A., Wlasich, E., Loosli, S. V., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1505999 · Cited by 1
Impact of the New Conceptual Framework of Alzheimer’s Disease in Imaging Studies
Dubois, B., Villain, N., Jacova, C., & Uspenskaya, O. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_13 · Cited by 1
de Natale, E. R., Wilson, H., Udeh‐Momoh, C. T., Ford, J. K., Politis, M., & Middleton, L. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00022-7 · Cited by 1
Localization of Network-Level Atrophy in Preclinical Alzheimer's DiseasePreprint
Lee, S., Baratono, S. R., Burt, G., Palm, S. T., Drew, W., Zide, B. S., Chiulli, N., Larivière, S., Fox, M., Sperling, R. A., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5977523/v1 · Cited by 1
Self-citationKinreich, S., Bingly, A., & Pandey, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.09.653177 · Cited by 1
Orthogonal Statistical Inference for Multimodal Data AnalysisPreprint
Dai, X., & Li, L. (2021) · arXiv (Cornell University)
Regional atrophy correlates of domain-specific episodic memory in early Alzheimer’s disease
Baumeister, H. (2021) · Lund University Publications Student Papers (Lund University)
The Relationship Between Funcation Connectivity and Amyloid Accumulation in AD Continuum
Ling, R., Yang, Y., Wei, L., & Fan, C. (2021) · International Congress on Image and Signal Processing (CISP) · doi:10.1109/cisp-bmei53629.2021.9624445
Preclinical Alzheimer’s disease: how to predict who will decline next year?
Hanseeuw, B. J., & Johnson, K. A. (2023) · Brain Communications · doi:10.1093/braincomms/fcad079
Self-citationSpatial association between distributed β-amyloid and tau varies with cognitionPreprint
Carbonell, F., McNicoll, C., Zijdenbos, A. P., Bedell, B. J., & Initiative, A. D. N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.27.559737
PERSPECTIVE ON RECENT UPDATES IN ALZHEIMER’S DISEASE
(2024) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2024/13.8.8264
Sin, M., Dowling, N. M., Roseman, J. M., Ahmed, A., & ZAMRINI, E. Y. (2025) · Neuropathology · doi:10.1111/neup.13029
Paulsen, A., Driscoll, I. F., Breidenbach, B. M., Glittenberg, M., Lose, S., Ma, Y., Sager, M. A., Carlsson, C., Gallagher, C., Hermann, B. P., et al. (2025) · medRxiv · doi:10.1101/2025.03.03.25323245
Modifiable risk factor profiles moderate the effect of β-amyloid pathology on cognition in aging
Bhade, M., Pezzoli, S., Giorgio, J., Ward, T. J., Winer, J. R., Harrison, T. M., Landau, S. M., & Jagust, W. J. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.05.001
Mizraji, E., Lin, J., & Pomi, A. (2025) · BioEssays · doi:10.1002/bies.70032
Trelle, A. N., Sheng, J., Wilson, E. N., Romero, A., Park, J., Deutsch, G. K., Sha, S. J., Greicius, M. D., Andreasson, K. I., Kerchner, G. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.20.660774
Self-citationAmyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
Xia, Y., Bourgeat, P., Doré, V., Fripp, J., Lim, Y. Y., Laws, S. M., Fowler, C. J., Rowe, C. C., Masters, C. L., Coulson, E. J., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70155
Nonamyloid-beta active immunization for the treatment of Alzheimer’s disease
Triplett, O., Varda, N., Decourt, B., & Sabbagh, M. N. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2551352
Understanding the Silent Threat: A Review to Neurodegenerative Disorders
Kajrolkar, A. (2025) · Premier Journal of Neuroscience · doi:10.70389/pjn.100012 · Cited by 1
Characterizing amyloid and tau PET-based stages across the clinical continuumPreprint
Cody, K. A., Sokołowski, A., Johns, E., Guerra, L. M., Winer, J. R., Young, C. B., Younes, K., Dumitrescu, L. C., Archer, D. B., Durant, A., et al. (2025) · medRxiv · doi:10.1101/2025.09.26.25336751
Self-citationApolipoprotein E gene allele 4 and amyloid-beta mediate tau-related network breakdown
Nabizadeh, F. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf404
Yukti, Sharma, A., Dhar, S., Ojha, R., & Prajapati, V. K. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.11.004
Seo, E. H., Lim, H. J., Yoon, H.-J., Choi, K. Y., Lee, J. J., Park, J. Y., Choi, S. H., Kim, H., Kim, B. C., & Lee, K. H. (2021) · Figshare · doi:10.6084/m9.figshare.16779366
Reas, E. T., Triebswetter, C., Banks, S. J., & McEvoy, L. K. (2024) · Figshare · doi:10.6084/m9.figshare.24987857
Prospect in Alzheimer’s disease integrative therapy targeting both amyloid-beta and tau
Zhang, W., Zhou, Y., Chen, J., Pérez, M., Claure, X., & Leblanc, R. M. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00916 · Cited by 1
Schwarck, S., Behrenbruch, N., Schumann‐Werner, B., Molloy, E. N., Garcia‐Garcia, B., Hochkeppler, A., Fischer, L., Büchel, A., Incesoy, E. I., Bernal, J., et al. (2026) · medRxiv · doi:10.64898/2026.01.14.26344098
Fenton, L. E., Aslanyan, V., Jacobs, D. M., Salmon, D. P., Brewer, J. B., Rissman, R. A., Shadyab, A. H., Harrison, T. M., Evans, A. C., LaCroix, A. Z., et al. (2026) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2026.109393
Verma, M., Raikwar, S., Beohar, M., Vishwakarma, N., & Sil, A. J. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814021126010004
Bax, F., Oltmer, J., Auger, C. A., Bonkhoff, A. K., Coughlan, G., Melloni, A. N., Jaisa-aad, M., Augustinack, J. C., Serrano‐Pozo, A., Frosch, M. P., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71206
Exploring of the the neural mechanisms of fatigue by passive induction
Ioannucci, S. (2022) · theses.fr (ABES) · doi:10.70675/dae7d651z6aefz4170z8365z14422797e54f
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
Pires, G. (2021) · theses.fr (ABES) · doi:10.70675/45826fd6zd2c8z4b3dz91e0za5080544cb17
Huang, Y., Gong, Q., Zhong, Z., & Guo, Q.-H. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02061-0
Zedde, M., Basso, G., Piazza, F., & Pascarella, R. (2026) · Springer eBooks · doi:10.1007/978-3-032-23618-0_7
Tau burden across Braak stages is associated with regionally specific amyloid accumulation
Rani, N., Alm, K. H., Callow, D. D., Zhu, Y., Pettigrew, C. A., Soldan, A., Lodge, M. A., Miller, M., Albert, M., & Bakker, A. (2026) · Brain Communications · doi:10.1093/braincomms/fcag184 · Cited by 1
Wu, J., Fang, T., Lv, X., Wang, Y., Gao, F., Shen, Y., Cheng, Z., & Shi, J. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70949
Dopamine Compensates for Amyloid-Induced Default Mode Network Dysfunction to Support LearningPreprint
Giorgio, J., Morin, T., Chen, H.-Y., Berry, A. S., Breakspear, M. J., & Jagust, W. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.07.736872
Tau physiology and pathology: impacts on cellular structures and neurodegenerative diseases
Akbari, V., & Bahramikia, S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02328-w
Amyloid-associated cognitive trajectories in aging dogs mirror early changes in humans
Vanderlip, C. R., Lingad, J. N., Treadwell, Z., Loritsch, J. M., Illeck, C. L., Ubele, M. F., Boaz, K., Mefford, J. L., Jones, E. D., Perpich, J. A., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.07.009
Jaganathan, R., Vijayakumar, S., Chen, Y., Ye, J., Bakthavatchalam, P., Wankhar, D., Yang, C., Iyaswamy, A., & Li, M. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107555
Liquid-liquid phase-separated tau colocalizes with and stabilizes Aβ oligomers
Jacob, T., Schützmann, M. P., Gerhards, L., Hruby, L., Leprivier, G., Tamgüney, G., & Hoyer, W. (2026) · Communications Chemistry · doi:10.1038/s42004-026-02165-6
Chiyanika, C., Chan, N. Y., Liu, W., Au, L. W. C., Chen, W., Liu, C., Chen, S., Leung, E. Y. L., Ho, C. L., Cai, Y., et al. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261491875
The relation of whole-brain functional connectivity to global amyloid and local tau presence
Ziadlou, D., Wales, R., Chen, X., & Leung, H.-C. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.10.007
Metadata
- Authors
- Sperling, R. A., Mormino, E. C., Schultz, A. P., Betensky, R. A., Papp, K. V., Amariglio, R. E., Hanseeuw, B. J., Buckley, R., Chhatwal, J., Hedden, T., Marshall, G. A., Quiroz, Y. T., Donovan, N. J., Jackson, J., Gatchel, J. R., Rabin, J. S., Jacobs, H., Yang, H., Properzi, M., Kirn, D. R., Rentz, D. M., & Johnson, K. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- Sperling, Reisa A.
- ORCID
- Sperling, Reisa A.
- Mormino, Elizabeth C.
- Schultz, Aaron P.
- Betensky, Rebecca A.
- Papp, Kathryn V.
- Amariglio, Rebecca E.
- Hanseeuw, Bernard J.
- Buckley, Rachel
- Chhatwal, Jasmeer
- Hedden, Trey
- Marshall, Gad A.
- Quiroz, Yakeel T.
- Donovan, Nancy J.
- Jackson, Jonathan
- Gatchel, Jennifer R.
- Rabin, Jennifer S.
- Jacobs, Heidi
- Yang, Hyun‐Sik
- Properzi, Michael
- Rentz, Dorene M.
- Johnson, Keith A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2019-01-21
- Volume
- 85
- Issue
- 2
- Pages
- 181-193
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC6402593
- OpenAlex
- W2905538154
- Cited by
- 286
- References
- 52
- Citations by year
- 2026: 22 · 2025: 57 · 2024: 42 · 2023: 29 · 2022: 29 · 2021: 52 · 2020: 38 · 2019: 17
- FWCI
- 20.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- National Institute on Aging (K24 AG035007, P01AG036694)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- amyloid-beta, tau protein, preclinical Alzheimer's disease, cognitive decline, memory decline, executive function, tau PET, normal aging, older adults, secondary prevention
- MeSH terms
- Aged, Aged, 80 and over, Female, Humans, Longitudinal Studies, Male, Amyloid beta-Peptides, tau Proteins, Positron-Emission Tomography, Cognitive Dysfunction, Memory, Episodic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
